- Home
- LFVN vs MXCT Comparison
LFVN vs MXCT Comparison
Compare LFVN & MXCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LFVN
- MXCT
- Stock Information
- Founded
- LFVN N/A
- MXCT 1999
- Country
- LFVN United States
- MXCT United States
- Employees
- LFVN N/A
- MXCT N/A
- Industry
- LFVN Biotechnology: Pharmaceutical Preparations
- MXCT Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- LFVN Health Care
- MXCT Health Care
- Exchange
- LFVN Nasdaq
- MXCT Nasdaq
- Market Cap
- LFVN 145.2M
- MXCT 148.2M
- IPO Year
- LFVN N/A
- MXCT 2021
- Fundamental
- Price
- LFVN $11.13
- MXCT $1.45
- Analyst Decision
- LFVN Strong Buy
- MXCT Buy
- Analyst Count
- LFVN 2
- MXCT 4
- Target Price
- LFVN $30.50
- MXCT $7.50
- AVG Volume (30 Days)
- LFVN 161.9K
- MXCT 834.3K
- Earning Date
- LFVN 10-28-2025
- MXCT 11-05-2025
- Dividend Yield
- LFVN 1.62%
- MXCT N/A
- EPS Growth
- LFVN 226.09
- MXCT N/A
- EPS
- LFVN 0.75
- MXCT N/A
- Revenue
- LFVN $228,530,000.00
- MXCT $35,754,000.00
- Revenue This Year
- LFVN $12.65
- MXCT N/A
- Revenue Next Year
- LFVN $12.43
- MXCT $14.79
- P/E Ratio
- LFVN $14.84
- MXCT N/A
- Revenue Growth
- LFVN 14.17
- MXCT N/A
- 52 Week Low
- LFVN $9.00
- MXCT $1.26
- 52 Week High
- LFVN $27.38
- MXCT $5.20
- Technical
- Relative Strength Index (RSI)
- LFVN 36.56
- MXCT 43.26
- Support Level
- LFVN $10.30
- MXCT $1.39
- Resistance Level
- LFVN $12.10
- MXCT $1.44
- Average True Range (ATR)
- LFVN 0.96
- MXCT 0.06
- MACD
- LFVN -0.22
- MXCT 0.04
- Stochastic Oscillator
- LFVN 20.85
- MXCT 76.47
About LFVN Lifevantage Corporation (Delaware)
Lifevantage Corp is engaged in the identification, research, development, and distribution of nutraceutical dietary supplements and skincare products. It offers products such as Protandim, a scientifically-validated dietary supplement; LifeVantage TrueScience, an anti-aging skincare product; Axio energy drink mixes; and PhysIQ, a weight management system and other product Geographically, its products are sold in the regions of the United States, Japan, Hong Kong, Australia, Canada, Philippines, Mexico, Thailand, the United Kingdom, and the Netherlands.
About MXCT MaxCyte Inc.
MaxCyte Inc is a commercial cell engineering company focused on providing enabling platform technologies to advance the discovery, development and commercialization of next-generation cell therapeutics and to support cell-based research and development. The company has developed and commercialized a proprietary Flow Electroporation platform, which facilitates the complex engineering of a wide variety of cells. The Company has one reportable segment, cell engineering technology. The revenue is generated from the sale and licensing of company's instruments, as well as sales of single-use disposable processing assemblies.